ClinConnect ClinConnect Logo
Search / Trial NCT06387875

Cohort in Qianwan New District, Ningbo

Launched by RENJI HOSPITAL · Apr 25, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Cohort Natural Population Non Communicable Chronic Disease

ClinConnect Summary

This clinical trial is focused on understanding how to prevent and manage chronic diseases like heart problems and strokes in the Qianwan New District of Ningbo. The goal is to develop a system that can help identify people at risk for these conditions early on. By doing this, the researchers hope to promote early detection and treatment, which can lead to better health outcomes and lower medical costs, ultimately helping people live longer, healthier lives.

To participate in this study, you need to be a permanent resident of the area and at least 18 years old. You should be able to communicate normally and not have any serious physical disabilities. Participants will voluntarily agree to join and will be asked to sign consent forms. Those who are temporary residents, have severe health issues, or do not wish to undergo follow-up checks will not be eligible. If you decide to participate, you can expect to contribute to important research that could help improve health care for everyone in your community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1) Local permanent residents aged 18 and above (including residents with household registration, or residents without household registration but with a permanent job);
  • 2) No serious physical disability, can communicate normally;
  • 3) Participate voluntarily and sign informed consent.
  • Exclusion Criteria:
  • 1) Temporary resident and floating population;
  • 2) There are serious health conditions unable to participate in the survey;
  • 3) Those who are unwilling to accept the follow-up inspection of the project.

About Renji Hospital

Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.

Locations

Shanghai, , China

Patients applied

0 patients applied

Trial Officials

Jun Pu, MD, PhD

Principal Investigator

Ningbo Hangzhou Bay Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported